OMER Q2 2019 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$27M+1516.5% YoY

Gross Profit

$27M99.8% margin

Operating Income

-$9M-34.9% margin

Net Income

-$14M-54.0% margin

EPS (Diluted)

$-0.29

QoQ Revenue Growth

+22.8%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$90M

Total Liabilities

$220M

Stockholders' Equity

-$130M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$2M	+1516.5%
Gross Profit	$27M	$2M	+1634.8%
Operating Income	-$9M	-$31M	+69.5%
Net Income	-$14M	-$34M	+57.1%